14th Pharmacovigilance 2017

14th Pharmacovigilance 2017

Conference Business

Thu, Nov 09, 2017, 02:30 PM -  Thu, Nov 09, 2017, 11:30 PM

http://www.virtueinsight.com/pharma/14th-Pharmacovigilance-2017/

Contact details
Kavitha
kavitha@virtueinsight.co.in
10-08-2017
Organiser : Virtue Insight
Location details
Kohinoor Continental Hotel
mumbai-maharashtra
400059
About us

14th Pharmacovigilance 2017

“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management”

9th November 2017, Kohinoor Continental Hotel, Mumbai, India

 

The Pharmacovigilance conference, organized yearly by Virtue Insight, is a unique event where key stakeholders gather with the aim of promoting patient safety and undertaking to continue work towards a more efficient pharmacovigilance system. This is the opportunity to engage and sit alongside the pioneers who are driving forward innovation in pharmacovigilance.

 

KEY SPEAKERS:

 

·         S SADHWANI, Drug controller of Maharashtra and Jt.Commissioner Drug, FDA

·         K. BANGARURAJAN, Deputy Drugs Controller, DDC(I), CDSCO

·         MUZAFFAR AHMAD, Member, Strategic Advisory Board on Health Millenium Alliance (Govt of India) and Member Council of India

·         DAARA B. PATEL, Secretary General, Indian Drug Manufacturers' Association

·         DEEPA ARORA, Vice President - Pharmacovigilance & Global Head - Drug Safety & Risk Management, Lupin

·         JEAN-CHRISTOPHE DELUMEAU, Head of Pharmacovigilance Asia-Pacific, Bayer HealthCare (Singapore)

·         MANISH VERMA, Director and Head of Medical Affairs, South Asia Zone, Sanofi

·         SARABJEET KAUR, Associate Vice President- Pharmacovigilance, APCER Life Sciences

·         AMBRISH SRIVASTAVA, Vice President: Medial Affairs,Clinical Research & Regulatory, Alkem Laboratories

·         VIKRAM GOTA, Associate Professor, ACTREC, Tata Memorial Centre

·         BHASWAT CHAKRABORTY, Senior VP & Chair, Research and Development Core Committee, Cadila

·         AVINASH R. KAKADE, Senior Director and Head of Pharmacovigilance, Cipla

·         SHUBHADEEP SINHA, Vice-President & Head (Global) - Clinical Development, Medical Affairs & Pharmacovigilance, Hetero Labs

·         RAHUL GUPTA, Vice President, Regulatory Affairs, USV

·         SUJAY SURESH KULKARNI, Senior Manager, Medical and Regulatory Affairs, GSK

·         MILIND ANTANI, Partner In-Charge - Pharma LifeSciences, Nishith Desai Associates

·         ABHAY PHANSALKAR, Head Clinical Trials, Cipla

·         DEEPTI SANGHAVI, Assistant Manager-Medical Writing, Tata Consultancy Services

·         RUCHIKA SINGHAL, Business Unit Head, AstraZeneca

·         GURPREET SINGH, Head of Vendor Management in PV, Novartis

·         NIDHI VAISH DAS, Drug Safety, Roche Pharmaceuticals

·         MANOJ SWAMINATHAN, Chief Manager / Head - Global Pharmacovigilance, Piramal

·         SHASHIDHAR SWAMY, Project Manager, Tata Consultancy Services

·         PRANJAL BORDOLOI, AVP - Medical Affairs and Pharmacovigilance, Veeda Clinical Research

·         RAJANI ROKADE, Founder-Director, PharmaSoulz

·         PRASHANT BODHE, Director, CliniSearch

Plus many more,,

 

WHO SHOULD ATTEND:

 

Vice Presidents, Directors, CRO’s, Heads and Managers of:

Pharmacovigilance Strategy, Drug Safety/Risk Management, Information and Clinical Data Management, Clinical Research, Research & Development, Product Safety/Assurance Assessment, Patient Safety & Outcomes Research & Data Analysis, Epidemiology project management, Regulatory Affairs and Compliance, Sales & Marketing, Biotech manufacturers

Pharmaceutical organizations, Generic pharmaceutical companies, Contract research organizations, Patient recruitment companies, Government- Department of health, Non-profit organizations/ Association, Consultants

 

CONFERENCE BOOKING DETAILS:-

 

Email – kavitha@virtueinsight.co.in  or TEL: + 91 9940791115

 

  • Early-Bird Discount until 26 September 2017 1 Delegate Pass – (INR 6,000 + GST (18%) per delegate).
  • Standard Price from 27 September 2017– 1 or 2 Delegates – (INR 7,000 + GST (18%) per delegate). 
  • Group Discounts – 3 or 4 Delegates – (INR 6,500 + GST (18%) per delegate)
  • Group Discounts – 5 and above Delegates  (INR 6,000 + GST (18%) per delegate)
  • Spot Registration on the day of the Conference – 1 Day Conference - (INR 8,000 + GST (18%) per delegate)

·         Conference Sponsor & Exhibition Stalls are also available. We also have sponsorship opportunities available for the event which gives you an opportunity to speak/exhibit and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.

 

REGISTRATION PROCESS:-

In order to register simply fill in the last page of the attached file and email us back to me or you can simply email me your invoice details in the below mentioned format;

·         Company Name & Address:

·         GST number (if applicable):

·         Attendee Name:

·         Job Title:

·         Contact Number:

 

Be a part of this conference and explore benefit-risk management strategies and patient-centric approaches and how you can tackle the challenges of social media and drug safety legislation globally.

 

Comments

find us on social media

SUBSCRIBE TO OUR NEWS LETTER

To stay updated with your interests and events